RECAP: Safeguard Scientifics First Quarter 2012 Financial Results
Here is a recap of our first quarter 2012 financial results. Our team is executing a focused and disciplined strategy that enhances Safeguard’s brand as…
Posted by
Here is a recap of our first quarter 2012 financial results. Our team is executing a focused and disciplined strategy that enhances Safeguard’s brand as…
Posted by
The first quarter of 2012 has come and gone, leaving positive signs for venture capitalists. Twenty venture-backed start-ups made their IPO in the past three…
Posted by
The same technologies driving Enterprise 3.0 have also been revolutionizing health management. This convergence of technology and healthcare has built up momentum recently through new…
Posted by
Readers of this blog are well aware that entrepreneurship is one of our key themes—from our partner company CEO Q&A Series to our book recommendations…
Posted by
The latest report from MoneyTree and the National Venture Capital Association shows that corporate venture capitalists (CVCs) increased investments over the past three years. In…
Posted by
Last year was a strong year for venture capital, according to the MoneyTree report issued by the National Venture Capital Association. Investments grew 22 percent…
Posted by
As 2011 comes to a close, it offers us an opportunity to look back at the major milestones and key events of the year. While…
Posted by
The convergence between life sciences and technology cannot be ignored. That’s why at Safeguard Scientifics, we consolidated of our life sciences and technology deal teams.…
Posted by